Location History:
- Evanston, IL (US) (2002)
- Columbus, IN (US) (2002 - 2004)
Company Filing History:
2 out of 2,483 
1 out of 1,651 
Years Active: 2002-2004
Title: Cristina Stadler: Innovating Medical Devices in Columbus, IN
Introduction:
Cristina Stadler is a talented inventor based in Columbus, IN, with a passion for creating innovative medical devices. With a total of 3 patents to her name, her work is revolutionizing the field of biochemically reactive fluid delivery.
Latest Patents:
Stadler's latest invention is the Mechanical Breakup Unit for Biochemically Reactive Fluid Delivery Device. This groundbreaking medical device enables the precise delivery of two biochemically reactive fluids, ensuring optimal atomization and spray patterns for medical applications. The device incorporates unique features such as spin chambers and funneling portions to achieve the desired fluid interaction.
Another notable invention by Stadler is the Fibrin Delivery Device and Method for Forming Fibrin on a Surface. This device facilitates the controlled delivery and mixing of biochemically reactive fluids onto a surface, enhancing the efficiency and accuracy of medical procedures involving fibrinogen and thrombin.
Career Highlights:
Stadler has made significant contributions to the medical device industry through her work at renowned companies such as Baxter International Inc. and Edwards Lifesciences Corporation. Her expertise in biochemically reactive fluid delivery systems has led to the development of cutting-edge technologies that improve patient outcomes and procedural efficiency.
Collaborations:
Throughout her career, Stadler has collaborated with industry experts such as Yves A Delmotte and Arnold C Bilstad. These collaborations have enriched her innovative process and brought diverse perspectives to her projects, resulting in successful outcomes and impactful inventions.
Conclusion:
Cristina Stadler's inventive spirit and dedication to advancing medical technologies have established her as a leading figure in the field of biochemically reactive fluid delivery. Her patents and collaborations reflect her commitment to excellence and innovation, paving the way for future advancements in the healthcare industry.